HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹152 Cr | ₹125 Cr | ₹105 Cr | ₹149 Cr | ₹97 Cr |
What is the latest Total Current Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹152 Cr |
| Mar2025 | ₹125 Cr |
| Mar2024 | ₹105 Cr |
| Mar2023 | ₹149 Cr |
| Mar2022 | ₹97 Cr |
How is Total Current Liabilities of HESTER BIOSCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹152 Cr | 21.80 | |
| Mar2025 | ₹125 Cr | 18.69 | |
| Mar2024 | ₹105 Cr | -29.07 | |
| Mar2023 | ₹149 Cr | 53.46 | |
| Mar2022 | ₹97 Cr | - | |
Compare Total Current Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,992.1 Cr | -1% | 9.2% | 43.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -1% |
9.2% |
43.9% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses